(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global Sepsis Diagnostics market is accounted for $330.74 million in 2015 and is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%. This life-threatening condition of Sepsis arises when the body's response to infection...
(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global Defibrillators market is accounted for $10.61 billion in 2015 and is expected to reach $19.31 billion by 2022 growing at a CAGR of 8.9%. The defibrillation is a procedure comprising of delivering an electric shock to the heart,...
(PharmaNewsWire.Com, June 29, 2017 ) Increased investments by governments across the world and growing importance of patient safety are some of the key factors driving the market growth. However, lack of standardization across the nations and improper management in adjusting these systems that leads...
(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global Sterile Filtration Market is accounted for $4.12 billion in 2015 and is expected to reach $9.57 billion by 2022 growing at a CAGR of 12.7% during the forecast period. Factors such as increasing prevalence of diabetes & kidney...
(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global E-Health Market is accounted for $99.35 billion in 2015 and is expected to reach $285.57 billion by 2022 growing at a CAGR of 16.2% during the forecast period. Factors such as growing occurrence of chronic diseases and technological...
(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global Clinical Microbiology Market is accounted for $3.05 billion in 2015 and is expected to reach $6.72 billion by 2022 growing at a CAGR of 11.9% during the forecast period. Growing prevalence of infectious diseases, technological...
(PharmaNewsWire.Com, June 29, 2017 ) According to Publisher, the Global Allergy Diagnostics Market is accounted for $2.70 billion in 2015 and is expected to reach $6.29 billion by 2022 growing at a CAGR of 12.8% during the forecast period. Factors such as rising healthcare expenses, growing environmental...
(PharmaNewsWire.Com, June 29, 2017 ) Growing pervasiveness of type 1 diabetes and ongoing approvals by the government authorities are nurturing the market growth. Some drivers such as growing population exposures, technological developments and favorable medical repayment scenario in developed countries...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Cholera-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Cholera. The Publisher's Report covers the product profiles in various stages of development including Discovery,...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Chikungunya-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Chikungunya. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced Peripheral Neuropathy. The Publisher's Report covers the...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Chemotherapy Induced Neutropenia-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced Neutropenia. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Cedar Pollen Allergy-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Cedar Pollen Allergy. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Cat Allergy-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Cat Allergy. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, June 29, 2017 ) Publisher's, "Cardiovascular Risk Factors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Cardiovascular Risk Factors. The Publisher's Report covers the product profiles in various...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
